Researchers continue to excited about the medication , a novel dual compound showing remarkable data in early trials for weight management. It acts by targeting two hormones : GLP-1 and GIP, which , when https://kobidarw800626.acidblog.net/72014321/this-new-prospect-for-weight-loss